Tag: Inovio
Synthetic alternative to monoclonal antibodies enter humans for the first time
US based Inovio Pharmaceuticals' DNA-encoded monoclonal antibody (dMAb™) platform has made a leap forward with first-in-human trial that will target Zika infection...............